Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition

BACKGROUND: The post‐COVID‐19 condition (PCC) consists of a wide array of symptoms including fatigue and impaired daily living. People seek a wide variety of approaches to help them recover. A new belief, arising from a few laboratory studies, is that 'microclots' cause the symptoms of PCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Tilly, Hunt, Beverley J, Ariens, Robert AS, Towers, Greg J, Lever, Robert, Garner, Paul, Kuehn, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368521/
https://www.ncbi.nlm.nih.gov/pubmed/37491597
http://dx.doi.org/10.1002/14651858.CD015775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368521/
https://www.ncbi.nlm.nih.gov/pubmed/37491597
http://dx.doi.org/10.1002/14651858.CD015775

Ejemplares similares